With the health care and pharmaceuticals sectors worth $18.3bn and $5.1bn in 2012 and 2013, respectively, according to reports from Alpen Capital, Saudi Arabia is a key target market for international businesses operating in both spheres. Statistics from the European Commission (EC), demonstrate the rapid growth in pharmaceutical exports from...